Company Profiles

driven by the PitchBook Platform

NormOxys

Description

Owner and operator of a biopharmaceutical firm. The company provides products that regulates the binding affinity between oxygen and hemoglobin and helps in the treatment of heart failure, diabetic retinopathy and cancer.

2003

Founded

PRIVATE

Status

11-50

Employees

Conv. Debt

Latest Deal Type

$600k

Latest Deal Amount

$29.8M

Total Amount Raised

Description

Owner and operator of a biopharmaceutical firm. The company provides products that regulates the binding affinity between oxygen and hemoglobin and helps in the treatment of heart failure, diabetic retinopathy and cancer.

Website:

www.normoxys.com

Formerly Known As

Oxyplus

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

300 Market Street Boston, MA 02135United States +1 (617) 719-9489
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore NormOxys's full profile, request a free trial.

NormOxys Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

NormOxys Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

NormOxys Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Care CapitalVenture CapitalMinority000 0000000 0000
Index VenturesVenture CapitalMinority000 0000000 0000
Care Capital Venture Capital
Index Ventures Venture Capital

NormOxys Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Conrad Bletzer JDChief Executive Officer, Board Member, General Counsel & Co-Founder
Claude Nicolau Ph.DCo-Founder, Chief Scientific Officer and Board Member
Jean-Marie Lehn Ph.DCo-Founder
John Hey Ph.DSenior Vice President, Preclinical and Early Development
Conrad Bletzer JD Chief Executive Officer, Board Member, General Counsel & Co-Founder
Claude Nicolau Ph.D Co-Founder, Chief Scientific Officer and Board Member
Jean-Marie Lehn Ph.D Co-Founder
John Hey Ph.D Senior Vice President, Preclinical and Early Development

NormOxys Board Members (5)

NameRepresentingRoleSinceContact
Info
Argeris Karabelas Ph.DCare CapitalPartner000 0000
Bart Van HoolandNormOxysBoard Member000 0000
Francesco De Rubertis Ph.DIndex VenturesPartner000 0000
Janwillem NaesensNormOxysBoard Member000 0000
Michèle Ollier MDIndex VenturesPartner000 0000
Argeris Karabelas Ph.D Partner Care Capital
Bart Van Hooland Board Member NormOxys
Francesco De Rubertis Ph.D Partner Index Ventures
Janwillem Naesens Board Member NormOxys
Michèle Ollier MD Partner Index Ventures
Request full access to PitchBook